A novel frameshift mutation in DNAH6 associated with male infertility and asthenoteratozoospermia
Frontiers in Endocrinology · 2023
DOI: 10.3389/fendo.2023.1122004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2023. Verfasst von Fei Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Department of Obstetrics and Gynecology, The Second Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Asthenozoospermia, Infertility, Male, Dyneins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Hunan Province.
Abstract (Originalsprache)
Introduction
Asthenoteratozoospermia is one of the most common causes of male infertility. Several genes have been identified as genetic causative factors, but there is a considerable genetic heterogeneity underlying asthenoteratozoospermia. In this study, we performed a genetic analysis of two brothers from a consanguineous Uighur family in China to identify gene mutations causative for asthenoteratozoospermia-related male infertility.
Methods
Two related patients with asthenoteratozoospermia from a large consanguineous family were sequenced by whole-exome sequencing and Sanger sequencing to identify disease-causing genes. Scanning and transmission electron microscopy analysis revealed ultrastructural abnormalities of spermatozoa. Quantitative real-time PCR (qRT-PCR) analysis and immunofluorescence (IF) analysis were used to assess the expression of the mutant messenger RNA (mRNA) and protein.
Results
A novel homozygous frameshift mutation (c.2823dupT, p.Val942Cysfs*21) in DNAH6 was identified in both affected individuals and was predicted to be pathogenic. Papanicolaou staining and electron microscopy revealed multiple morphological and ultrastructural abnormalities of affected spermatozoa. qRT-PCR and IF analysis showed abnormal expression of DNAH6 in affected sperm, probably due to premature termination code and decay of abnormal 3′ untranslated region (UTR) region of mRNA. Furthermore, intracytoplasmic sperm injection could achieve successful fertilization in infertile men with DNAH6 mutations.
Discussion
The novel frameshift mutation identified in DNAH6 may contribute to asthenoteratozoospermia. These findings expand the spectrum of genetic mutations and phenotypes associated with asthenoteratozoospermia and may be useful for genetic and reproductive counseling in male infertility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, Department of Obstetrics and Gynecology, The Second Xiangya Hospital, Central South University, Changsha, China.
Förderung
- National Natural Science Foundation of China
- Science and Technology Program of Hunan Province
Zitieren
APA
Huang, F., Zeng, J., Liu, D., Zhang, J., Liang, B., Gao, J., Yan, R., Shi, X., Chen, J., Song, W., & Huang, H. L. (2023). A novel frameshift mutation in DNAH6 associated with male infertility and asthenoteratozoospermia. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2023.1122004
Vancouver
Huang F, Zeng J, Liu D, Zhang J, Liang B, Gao J, et al. A novel frameshift mutation in DNAH6 associated with male infertility and asthenoteratozoospermia. Frontiers in Endocrinology. 2023. doi:10.3389/fendo.2023.1122004
BibTeX
@article{Huang2023,
author = {Huang, Fei and Zeng, Jun and Liu, Dan and Zhang, Jing and Liang, Boluo and Gao, Jingping and Yan, Rong and Shi, Xiaobo and Chen, Jianlin and Song, Wanjuan and Huang, Hua-Lin},
title = {A novel frameshift mutation in DNAH6 associated with male infertility and asthenoteratozoospermia},
journal = {Frontiers in Endocrinology},
year = {2023},
doi = {10.3389/fendo.2023.1122004}
}
EUVIMED